BridgeBio Pharma's total assets for Q1 2025 were $881.64M, a decrease of -4.10% from the previous quarter. BBIO total liabilities were $2.52B for the fiscal quarter, a 6.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.